vs

Side-by-side financial comparison of CME Group (CME) and MNTN, Inc. (MNTN). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $73.7M, roughly 25.5× MNTN, Inc.). MNTN, Inc. runs the higher net margin — 11.9% vs 0.1%, a 11.8% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 14.2%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

MNTN Inc. is a U.S.-headquartered advertising technology firm specializing in performance-driven connected TV (CTV) advertising solutions. It serves e-commerce, retail, and consumer goods brands, helping clients accurately measure ad campaign ROI and reach targeted audiences across streaming TV platforms in North American and European markets.

CME vs MNTN — Head-to-Head

Bigger by revenue
CME
CME
25.5× larger
CME
$1.9B
$73.7M
MNTN
Growing faster (revenue YoY)
CME
CME
+0.3% gap
CME
14.5%
14.2%
MNTN
Higher net margin
MNTN
MNTN
11.8% more per $
MNTN
11.9%
0.1%
CME

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CME
CME
MNTN
MNTN
Revenue
$1.9B
$73.7M
Net Profit
$1.2M
$8.8M
Gross Margin
2748.6%
Operating Margin
0.1%
31.5%
Net Margin
0.1%
11.9%
Revenue YoY
14.5%
14.2%
Net Profit YoY
20.7%
141.5%
EPS (diluted)
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
MNTN
MNTN
Q1 26
$1.9B
$73.7M
Q4 25
$1.6B
Q3 25
$1.5B
$70.0M
Q2 25
$1.7B
$68.5M
Q1 25
$1.6B
Q4 24
$1.5B
Q3 24
$1.6B
Q2 24
$1.5B
Net Profit
CME
CME
MNTN
MNTN
Q1 26
$1.2M
$8.8M
Q4 25
$1.2B
Q3 25
$908.0M
$6.4M
Q2 25
$1.0B
$-26.2M
Q1 25
$956.2M
Q4 24
$874.6M
Q3 24
$912.8M
Q2 24
$883.2M
Gross Margin
CME
CME
MNTN
MNTN
Q1 26
2748.6%
Q4 25
Q3 25
78.9%
Q2 25
76.8%
Q1 25
Q4 24
Q3 24
Q2 24
Operating Margin
CME
CME
MNTN
MNTN
Q1 26
0.1%
31.5%
Q4 25
61.8%
Q3 25
63.3%
10.8%
Q2 25
66.7%
5.4%
Q1 25
67.5%
Q4 24
62.1%
Q3 24
64.6%
Q2 24
65.3%
Net Margin
CME
CME
MNTN
MNTN
Q1 26
0.1%
11.9%
Q4 25
71.7%
Q3 25
59.1%
9.2%
Q2 25
60.6%
-38.3%
Q1 25
58.2%
Q4 24
57.3%
Q3 24
57.6%
Q2 24
57.6%
EPS (diluted)
CME
CME
MNTN
MNTN
Q1 26
$0.11
Q4 25
$3.24
Q3 25
$2.49
$0.08
Q2 25
$2.81
$-0.65
Q1 25
$2.62
Q4 24
$2.40
Q3 24
$2.50
Q2 24
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
MNTN
MNTN
Cash + ST InvestmentsLiquidity on hand
$2.4B
$213.9M
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$318.6M
Total Assets
$202.0B
$375.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
MNTN
MNTN
Q1 26
$2.4B
$213.9M
Q4 25
$4.5B
Q3 25
$2.6B
$179.2M
Q2 25
$2.1B
$175.2M
Q1 25
$1.5B
Q4 24
$3.0B
Q3 24
$2.4B
Q2 24
$1.9B
Total Debt
CME
CME
MNTN
MNTN
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CME
CME
MNTN
MNTN
Q1 26
$318.6M
Q4 25
$28.7B
Q3 25
$28.2B
$266.7M
Q2 25
$27.7B
$238.9M
Q1 25
$27.0B
Q4 24
$26.5B
Q3 24
$28.2B
Q2 24
$27.6B
Total Assets
CME
CME
MNTN
MNTN
Q1 26
$202.0B
$375.1M
Q4 25
$198.4B
Q3 25
$187.1B
$335.9M
Q2 25
$179.9B
$337.0M
Q1 25
$157.8B
Q4 24
$137.4B
Q3 24
$137.8B
Q2 24
$123.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
MNTN
MNTN
Operating Cash FlowLast quarter
$7.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.81×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
MNTN
MNTN
Q1 26
$7.1M
Q4 25
$1.1B
Q3 25
$968.1M
$9.3M
Q2 25
$1.1B
$17.6M
Q1 25
$1.1B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$776.9M
Free Cash Flow
CME
CME
MNTN
MNTN
Q1 26
Q4 25
$1.1B
Q3 25
$949.7M
Q2 25
$1.0B
Q1 25
$1.1B
Q4 24
$991.7M
Q3 24
$973.2M
Q2 24
$758.7M
FCF Margin
CME
CME
MNTN
MNTN
Q1 26
Q4 25
66.8%
Q3 25
61.8%
Q2 25
61.5%
Q1 25
67.1%
Q4 24
65.0%
Q3 24
61.4%
Q2 24
49.5%
Capex Intensity
CME
CME
MNTN
MNTN
Q1 26
Q4 25
2.0%
Q3 25
1.2%
Q2 25
1.1%
Q1 25
0.9%
Q4 24
1.7%
Q3 24
1.9%
Q2 24
1.2%
Cash Conversion
CME
CME
MNTN
MNTN
Q1 26
0.81×
Q4 25
0.96×
Q3 25
1.07×
1.45×
Q2 25
1.03×
Q1 25
1.17×
Q4 24
1.16×
Q3 24
1.10×
Q2 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons